glutathione mutations in sclc patients

glutathione mutations in sclc patients Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation | Cancer & Metabolism Integrated methylome analysis identifies an

Name: glutathione mutations in sclc patients Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation | Cancer & Metabolism Integrated methylome analysis identifies an
Brand: l2q2.es
SKU: 96444229470
Price: 27.48 USD
Availability: InStock
Rating: 4.3627 (7 reviews)

Integrated methylome analysis identifies an epigenetically silenced tumor suppressor RASA4 in small cell lung cancer Communications Biology Antibody drug conjugates: A new twist to overcome EGFR TKIs resistance in non small cell lung cancer ScienceDirect NRF2 supports non small cell lung cancer growth independently of CBP p300 enhanced glutathione synthesis EMBO Reports Springer Nature Link Frontiers Metabolic reprogramming in lung cancer and its clinical implication

SKU: 96444229470 · From l2q2.es

4.4

USD27.48 USD56.48

Pay in 4 interest-free payments of $6.87 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

FDA Orange Book

The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 20052008